Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2020 Filed Jun 9, 2020 00:34 UTC |
Schoeneck James ADirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035158 · doc4.xml · nonDerivative · entry 1 Schoeneck James A · CIK 0001420987 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,400 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:33 UTC |
Rosenkranz Roberto PedroDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035157 · doc4.xml · derivative · entry 2 Rosenkranz Roberto Pedro · CIK 0001621332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:33 UTC |
Rosenkranz Roberto PedroDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035157 · doc4.xml · nonDerivative · entry 1 Rosenkranz Roberto Pedro · CIK 0001621332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,100 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:32 UTC |
RIGGS RORY BDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035155 · doc4.xml · derivative · entry 3 RIGGS RORY B · CIK 0001016835 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F3 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:32 UTC |
RIGGS RORY BDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035155 · doc4.xml · nonDerivative · entry 1 RIGGS RORY B · CIK 0001016835 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,050 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:31 UTC |
Lema GeraldDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035154 · doc4.xml · derivative · entry 3 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:31 UTC |
Lema GeraldDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035154 · doc4.xml · nonDerivative · entry 1 Lema Gerald · CIK 0001717617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,400 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:30 UTC |
Kurkijarvi KaleviDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035153 · doc4.xml · derivative · entry 2 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:30 UTC |
Kurkijarvi KaleviDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035153 · doc4.xml · nonDerivative · entry 1 Kurkijarvi Kalevi · CIK 0001621333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,100 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:28 UTC |
KEARNS THOMAS F JRDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035152 · doc4.xml · derivative · entry 3 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:28 UTC |
KEARNS THOMAS F JRDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035152 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,164 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:27 UTC |
Ho MaykinDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035150 · doc4.xml · derivative · entry 2 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:27 UTC |
Ho MaykinDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035150 · doc4.xml · nonDerivative · entry 1 Ho Maykin · CIK 0001646395 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,255 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:26 UTC |
Henderson Jeffrey WilliamDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035148 · doc4.xml · derivative · entry 2 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:26 UTC |
Henderson Jeffrey WilliamDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035148 · doc4.xml · nonDerivative · entry 1 Henderson Jeffrey William · CIK 0001324015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,100 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:25 UTC |
EDWARDS JEFFREY LDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035147 · doc4.xml · derivative · entry 2 EDWARDS JEFFREY L · CIK 0001190642 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:25 UTC |
EDWARDS JEFFREY LDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035147 · doc4.xml · nonDerivative · entry 1 EDWARDS JEFFREY L · CIK 0001190642 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,100 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:23 UTC |
Blaug SuzanneDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $32.69 | $0.00 |
DisclosureSEC source: 0001209191-20-035146 · doc4.xml · derivative · entry 2 Blaug Suzanne · CIK 0001778430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2030-06-03 F2 · derivative.exercise_date: Options vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| June 04, 2020 Filed Jun 9, 2020 00:23 UTC |
Blaug SuzanneDirector
|
GrantCommon Stock | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035146 · doc4.xml · nonDerivative · entry 1 Blaug Suzanne · CIK 0001778430 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,348 F1 · shares: Represents the grant of restricted stock units that vest on the earlier of June 4, 2021 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,345 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · derivative · entry 13 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,719 Underlying: Common Stock · 7,345 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2018, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 6,215 | $26.08 | $162,087.20 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 10 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,013 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F9 · price: The shares were sold at prices ranging from $25.71 to $26.525. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 830 | $25.32 | $21,015.60 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 9 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,228 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F8 · price: The shares were sold at prices ranging from $24.71 to $25.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 300 | $23.93 | $7,179.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 8 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,058 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F7 · price: The shares were sold at prices ranging from $23.50 to $24.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
Exercise / conversionCommon Stock | 7,345 | $25.40 | $186,563.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 7 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:37 UTC |
KEARNS THOMAS F JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-20-020706 · doc4.xml · derivative · entry 5 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:37 UTC |
KEARNS THOMAS F JRDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $2.90 | $0.00 |
DisclosureSEC source: 0001209191-20-020706 · doc4.xml · derivative · entry 4 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2020-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:37 UTC |
KEARNS THOMAS F JRDirector
|
SaleCommon Stock | 18,000 | $23.17 | $417,074.40 |
DisclosureSEC source: 0001209191-20-020706 · doc4.xml · nonDerivative · entry 2 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,464 F1 · price: The shares were sold at prices ranging from $22.67 to $23.55. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 19, 2020 Filed Mar 23, 2020 21:37 UTC |
KEARNS THOMAS F JRDirector
|
Exercise / conversionCommon Stock | 18,000 | $2.90 | $52,200.00 |
DisclosureSEC source: 0001209191-20-020706 · doc4.xml · nonDerivative · entry 1 KEARNS THOMAS F JR · CIK 0001189184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 400 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · derivative · entry 12 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,064 Underlying: Common Stock · 400 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2018, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 1,500 | $25.68 | $38,520.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,013 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F6 · price: The shares were sold at prices ranging from $25.26 to $26.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 1,500 | $24.56 | $36,840.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,513 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F5 · price: The shares were sold at prices ranging from $24.13 to $25.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 905 | $23.69 | $21,439.45 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,013 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $23.10 to $24.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
Exercise / conversionCommon Stock | 400 | $25.40 | $10,160.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:05 UTC |
Yu K PeonyChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $26.41 | $0.00 |
DisclosureSEC source: 0001209191-20-020123 · doc4.xml · derivative · entry 5 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2030-03-17 F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:05 UTC |
Yu K PeonyChief Medical Officer
|
GrantCommon Stock | 45,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020123 · doc4.xml · nonDerivative · entry 3 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 211,541 F2 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:03 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
GrantStock Option (Right to Buy) · Derivative | 62,500 | $0.00 Strike: $26.41 | $0.00 |
DisclosureSEC source: 0001209191-20-020121 · doc4.xml · derivative · entry 3 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2030-03-17 F3 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests March 1, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:03 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020121 · doc4.xml · nonDerivative · entry 2 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,191 F2 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:00 UTC |
Cotroneo PatSVP, Finance and CFO
|
GrantStock Option (Right to Buy) · Derivative | 66,250 | $0.00 Strike: $26.41 | $0.00 |
DisclosureSEC source: 0001209191-20-020120 · doc4.xml · derivative · entry 4 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,250 Underlying: Common Stock · 66,250 shares Expires 2030-03-17 F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 00:00 UTC |
Cotroneo PatSVP, Finance and CFO
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020120 · doc4.xml · nonDerivative · entry 3 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,466 F3 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
GrantStock Option (Right to Buy) · Derivative | 66,250 | $0.00 Strike: $26.41 | $0.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · derivative · entry 11 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,250 Underlying: Common Stock · 66,250 shares Expires 2030-03-17 F10 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,518 F2 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:05 UTC |
Yu K PeonyChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-20-020123 · doc4.xml · derivative · entry 4 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,250 Underlying: Common Stock · 3,750 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:05 UTC |
Yu K PeonyChief Medical Officer
|
Exercise / conversionCommon Stock | 3,750 | $19.39 | $72,712.50 |
DisclosureSEC source: 0001209191-20-020123 · doc4.xml · nonDerivative · entry 2 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:00 UTC |
Cotroneo PatSVP, Finance and CFO
|
SaleCommon Stock | 9,239 | $26.36 | $243,540.04 |
DisclosureSEC source: 0001209191-20-020120 · doc4.xml · nonDerivative · entry 2 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,466 F2 · shares: Shares sold pursuant to a 10b5-1 plan. Read SEC document |
| March 06, 2020 Filed Mar 19, 2020 00:05 UTC |
Yu K PeonyChief Medical Officer
|
Tax withholdingCommon Stock | 9,826 | $39.71 | $390,190.46 |
DisclosureSEC source: 0001209191-20-020123 · doc4.xml · nonDerivative · entry 1 Yu K Peony · CIK 0001621328 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,791 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 06, 2020 Filed Mar 19, 2020 00:03 UTC |
Kouchakji EliasSVP, Clinical Dev, Drug Safety
|
Tax withholdingCommon Stock | 6,525 | $39.71 | $259,107.75 |
DisclosureSEC source: 0001209191-20-020121 · doc4.xml · nonDerivative · entry 1 Kouchakji Elias · CIK 0001775259 · SVP, Clinical Dev, Drug Safety 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,691 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 06, 2020 Filed Mar 19, 2020 00:00 UTC |
Cotroneo PatSVP, Finance and CFO
|
Tax withholdingCommon Stock | 4,881 | $39.71 | $193,824.51 |
DisclosureSEC source: 0001209191-20-020120 · doc4.xml · nonDerivative · entry 1 Cotroneo Pat · CIK 0001621334 · SVP, Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,705 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| March 06, 2020 Filed Mar 19, 2020 23:55 UTC |
Chung ChristineSVP, China Operations
|
Tax withholdingCommon Stock | 10,126 | $39.71 | $402,103.46 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,518 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 22:36 UTC |
Chung ChristineSVP, China Operations
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-009365 · doc4.xml · derivative · entry 7 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,464 Underlying: Common Stock · 5,625 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2018, and the remainder vested in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 22:36 UTC |
Chung ChristineSVP, China Operations
|
SaleCommon Stock | 600 | $46.28 | $27,768.00 |
DisclosureSEC source: 0001209191-20-009365 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,644 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $46.22 to $46.435. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.